Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)
Conditions
Alagille Syndrome · Progressive Familial Intrahepatic Cholestasis
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cliniques Universitaires Saint Luc (UCLouvain), Brussels, Belgium
University Hospital Gent (UZ Gent), Ghent, Belgium
Hospices Civils de Lyon - Hopital Femme Mère Enfant, Bron, Auvergne-Rhône-Alpes, France
CHU de Toulouse - Hôpital des Enfants, Toulouse, Occitanie, France
Bicetre University Hospital, Le Kremlin-Bicêtre, Île-de-France Region, France
Charite Berlin, Berlin, Germany
Children's University Hospital Essen, Essen, Germany
University Hospital Hamburg-Eppendorf, Hamburg, Germany
Contact: Study coordinator (Sebastian Schulz-Jürgensen) · s.schulz-juergensen@uke.de · +49 40 7410 527022nd Paediatric Clinic P &A Kyriakou Children's Hospital, Athens, Greece
Contact: Study coordinator (Aglaia Zellos)AO Ospedale PAPA GIOVANNI XXIII, Bergamo, Lombardy, Italy
Istituto mediterraneo trapianti - ISMETT, Palermo, Sicily, Italy
University Medical Center Groningen (UMCG), Groningen, Netherlands
Unidade Local de Saude de Coimbra Paediatric Department Avenida Afonso Romăo, Coimbra, Portugal
Contact: Study coordinator (Isabel Goncalves Costa)Hospital Universitairo Vall D'Hebron, Barcelona, Catalonia, Spain
Hospital Universitario La Paz, Madrid, Spain